August 07, 2024
A New Jersey federal judge granted a Hong Kong firm a default win in its suit alleging a U.S. health company misappropriated a $10 million investment by overselling its ability to manufacture and sell face masks in the U.S. during the COVID-19 pandemic, ruling that the company has plausibly alleged its claims.
June 16, 2023
A Hong Kong company has accused a New Jersey business and its CEO of exaggerating its ability to get a facility up and running to manufacture, distribute and sell face masks in the U.S. during the COVID-19 pandemic and misappropriating a $10 million investment.